Govt Job: For M.Pharm, M.Sc, M.Tech as Senior Research Fellow at AIIMS

The All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object of developing patterns of teaching in undergraduate and post-graduate medical education in all its branches so as to demonstrate a high standard of medical education in India; bringing together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity, and attaining self-sufficiency in post-graduate medical education.

Senior Research Fellow (SRF).

Applications are invited from interested candidates to fulfill the vacancy of one Senior Research Fellow (SRF) post in an ICMR-funded project, on a purely temporary basis.

Awareness of head injury while driving in patients with epilepsy (PWE): A preventive and public educational study (1-1067; 2019-2023)”

Salary: As per ICMR guidelines

Project Duration: Till Jan 2023
Age35 years

Eligibility
Essential :
1. M.Sc. (Life Sciences), MA (Social Science), and Master in Medical Social Work (MSW) degree holders. OR

2. MBBS / BDS / MVSc / M.Pharma / ME / M.Tech degree holders. With Two years of Research

Experience:
Desirable: Candidates with Medical backgrounds and previous Research Experience in Neurology will be preferred.

Interested candidates are requested to send their up-to-date curriculum vitae to aiimsneuroproject@gmail.com clearly mentioning the subject “Application for the post of SRF position for ICMR project”. Only shortlisted candidates will be called for an interview.

The last date to send curriculum vitae is 11.08.2022.

Related Posts

  • Pharma
  • June 25, 2025
  • 95 views
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…

  • Pharma
  • June 25, 2025
  • 110 views
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India